Fact CheckerSign in

NCT06702787Enrolling by invitation

Mechanical Thrombectomy in the Middle East and North Africa: Interim Results from the MEMENTO Registry

Source: ClinicalTrials.gov · Last updated 25 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The MEMENTO (MEchanical thrMobectomy NETwork for MENA TOgether) Registry is a multicenter, prospective observational study aiming to evaluate the effectiveness, safety, and cost-effectiveness of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to large vessel occlusions (LVO) in the Middle East and North Africa (MENA) region. This interim analysis reports on the first 499 patients enrolled, assessing clinical outcomes, procedural details, and economic implications.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
1500 (estimated)
First submitted
14 Nov 2024
Start date
11 Mar 2022
Primary completion date
11 Apr 2025
Lead sponsor
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Diseases
Stroke
NCT number
NCT06702787

What you commit to

  • Study type: Observational
  • Planned participants: 1500
  • From 11 Mar 2022 to the primary completion date, 11 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Absence of confirmed LVO or MeVO. Pre-stroke mRS score of 6. Known severe comorbid conditions precluding MT. Inability to obtain informed consent. Patients not treated with MT.

Who the study is looking for

  • Adults aged 18 years and older (no upper age limit). Diagnosed with acute ischemic stroke due to confirmed large vessel occlusion (LVO) or medium vessel occlusion (MeVO).
  • Underwent mechanical thrombectomy (MT) with or without prior intravenous thrombolysis (IV tPA).
  • Pre-stroke modified Rankin Scale (mRS) score of 0-5. Consent to participate in the registry (by patient or legal representative).

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alexandria University Stroke network
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.